Profiel
Andy Rittenberg is currently Chief Legal Officer at Coherus Oncology, Inc. from 2024 to present.
Formerly, Mr. Rittenberg was Chief Compliance Officer & Senior VP-Legal at Gilead Sciences, Inc. from 2006 to 2023, and Attorney at Covington & Burling LLP from 1999 to 2006.
Education includes graduate studies at The University of Chicago and undergraduate studies at Yale University.
Actieve functies van Andy Rittenberg
| Bedrijven | Functie | Begin |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Algemeen Adviseur | 01-01-2024 |
Eerdere bekende functies van Andy Rittenberg
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Compliance Officer | 01-08-2023 |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-04-2006 |
Opleiding van Andy Rittenberg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
















